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AbstrACt
Objective Population-based risk assessment, using 
genetic testing and the provision of appropriate risk 
management, could lead to prevention, early detection 
and improved clinical management of ovarian cancer (OC). 
Previous research with mostly white British participants 
found positive attitudes towards such a programme. The 
current study aimed to explore the attitudes of South Asian 
(SA) women and men in the UK with the aim of identifying 
how best to implement such a programme to minimise 
distress and maximise uptake.
Design Semistructured qualitative focus group 
discussions.
setting Community centres across North London and 
Luton.
Participants 49 women and 13 men who identified as SA 
(Indian, Pakistani or Bangladeshi), which constitutes the 
largest non-European ethnic minority group in the UK.
Methods Seven community-based focus groups were 
held. Group discussions were transcribed verbatim, coded 
and analysed thematically.
results Awareness and knowledge of OC symptoms 
and specific risk factors was low. The programme was 
acceptable to most participants and attitudes to it were 
generally positive. Participants’ main concerns related 
to receiving a high-risk result following the genetic test. 
Younger women may be more cautious of genetic testing, 
screening or risk-reducing surgery due to the importance 
of marriage and childbearing in their SA cultures.
Conclusions A crucial first step to enable implementation 
of population-based genetic risk assessment and 
management in OC is to raise awareness of OC within 
SA communities. It will be important to engage with the 
SA community early on in programme implementation to 
address their specific concerns and to ensure culturally 
tailored decision support.
IntrODuCtIOn 
Ovarian cancer (OC) is the sixth most 
common cancer among UK women.1 Due to 
the non-specific symptoms associated with 
this cancer, diagnosis is usually at a late stage 
when prognosis is poor.2 
Earlier detection of OC could help to 
save lives and this has fuelled voluntary 
sector demands for research to investigate 
approaches for prevention and earlier diag-
nosis.3 A definitive ongoing trial investi-
gating screening for OC in postmenopausal 
women has shown this to be sensitive and 
feasible,4 5 but to date without a significant 
mortality benefit.5 6 Nevertheless, a stage 
shift at diagnosis has been evidenced and for 
high-risk women who are not ready to have 
risk-reducing surgery,5 screening could be an 
interim option.
Mutations of BRCA1 and BRCA2 genes 
considerably increase an individual’s risk of 
OC;7 combined with non-genetic information 
(eg, family history of cancer, age and lifestyle 
factors), this genetic information can be used 
to estimate a woman’s risk. Following risk 
assessment, risk-stratified management could 
strengths and limitations of this study
 ► This is the first study to explore the attitudes of a UK 
ethnic minority group towards population-based risk 
assessment and stratified management for ovarian 
cancer.
 ► The study explored the attitudes of both women and 
men.
 ► Opinions solicited during the focus groups were 
directly related to information provided about pop-
ulation-based risk assessment and stratified man-
agement for ovarian cancer and this may have 
limited responses.
 ► Two female researchers facilitated all the focus 
groups including those with men, this may have in-
fluenced the findings.
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benefit patients by identifying those at high risk and in 
most need of management, while avoiding overinves-
tigation of those at lowest risk.8 9 A current programme 
of research, Predicting Risk of Ovarian Malignancies, 
Improved Screening and Early Detection (PROMISE, 
https:// eveappeal. org. uk/ our- research/ our- research- 
programmes/ promise- 2016/), involves a feasibility trial 
to investigate whether stratified OC risk management is 
acceptable to women in the UK general population. In 
this programme, women will be provided with an esti-
mate of their OC risk and stratified as low, intermediate 
or high risk. Those with the lowest risk will be provided 
with information on OC. Screening or surgery to remove 
the ovaries will be offered to those at intermediate and 
high risk. In the future, equivalent programmes could be 
rolled out for other cancers.10
Positive attitudes to the PROMISE programme were 
reported among women in the general11 and in high 
OC risk populations,12 but study samples did not reflect 
the diverse UK population. A key concern for any public 
health programme is its inclusivity, yet little is known 
about UK ethnic minority peoples’ awareness and atti-
tudes towards genetic testing for cancer risk.13 The few 
studies that have explored delayed use of genetic services 
among UK minority groups identify low awareness of 
their availability, language barriers and unwillingness 
to discuss cancer due to stigma and fear as contributing 
factors.14 15
This study aimed to explore South Asian (SA) women’s 
and men’s attitudes towards the PROMISE programme 
and the idea of population-based genetic testing and 
risk-stratified management of OC, and to identify factors 
which may influence participation. The SA community is 
the largest non-European ethnic minority group in the 
UK, over 5% of the population in England and Wales 
identify as SA (Pakistani, Bangladeshi and Indian).16 
The attitudes of both men and women were explored 
because it is known that healthcare decisions may be 
influenced by family members including husbands and/
or fathers.17 18
MethODs
Methodological approach
The study took a constructionist perspective in which 
meaning and experience are considered to be socially 
produced and reproduced rather than as immutable 
individual characteristics.19 It used a qualitative research 
design of focus groups to explore existing knowledge 
of OC and views of the novel population-based risk 
management intervention. Focus groups are well suited 
to exploration of public health topics and are a good way 
of identifying community norms and cultural values.20 
Structured discussion within the groups provided an 
opportunity for participants to question each other and 
reflect on and challenge one another’s views. Thematic 
analysis of these data was undertaken.
Patient/public involvement
Patients and the public were involved as project steering 
group members in the design of the overall PROMISE 
programme and the health behaviour workstream within 
which this study was delivered. Members of the SA 
community also contributed by pilot testing our presenta-
tion materials for the focus groups.
setting
Participants were recruited from the North London 
Boroughs of Brent, Newham and Tower Hamlets and 
Luton, areas which have large SA settler communities. 
Groups were conducted in suitable local community 
venues between November 2016 and April 2017.
Participants
Purposive sampling was used to include only individ-
uals ≥18 years old, who self-identified as being of SA 
ethnicity (Indian, Pakistani, Bangladeshi) and to include 
a wide spread of ages. At least some conversational English 
language was needed to take part. Men were included 
in the study as they may play a role in supporting and 
advising female family members’ healthcare decisions. 
Women were excluded if they had (1) a diagnosis of OC 
and/or (2) previously had genetic testing to find out 
about personal cancer risk.
SA women and men were introduced to the study by local 
community centre staff (n=53), and through poster and 
leaflet advertisement at community centres and by a local 
women’s health organisation (n=9). The few eligible indi-
viduals who contacted the research team directly by phone 
or email were sent the study information and had an oppor-
tunity to ask questions. We aimed to obtain a broad range of 
views and continued to recruit until we achieved data satu-
ration,21 when no new views were being expressed. Of those 
who agreed to participate, two withdrew due to sickness. 
Participants received a £20 gift voucher and travel costs.
Data collection
Seven focus group discussions were held at community 
centres: five with women (n=12, n=8, n=9, n=11, n=9) and 
two with men (n=7, n=6). Each discussion lasted approxi-
mately 75 min. Groups were facilitated by NA, a SA multi-
lingual senior qualitative researcher and KEJH, a research 
assistant with a master’s level qualification, acting as 
moderator and note-taker alternatively. A semistructured 
discussion guide developed from previous work11 and the 
literature and which comprised open-ended, none-direc-
tive questions, was used (see online supplementary addi-
tional files 1 and 2). These aimed to facilitate discussion 
and elicit participant views.
At the start of each focus group, KEJH and NA intro-
duced themselves briefly (name, job, associated univer-
sity), stated the study’s purpose and confirmed what 
participation involved. Intragroup confidentiality, 
audio recording and study report confidentiality were 
highlighted with an opportunity to ask questions. Each 
participant completed a demographic questionnaire.
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To open the discussion participants were invited to 
share their current awareness and knowledge of OC. 
Essential information concerning OC, including the 
increased risk among those with BRCA1/2 gene muta-
tions, the possibility to test for these and the PROMISE 
programme’s proposal to offer OC risk-stratified manage-
ment (see online supplementary additional file 3), was 
then given in a short slide presentation and handout. It 
was also explained that OC risk information from genetic 
testing could be less accurate for women of SA ethnicity 
as most research has been carried out with women of 
European descent.22 The presentation text was designed 
to be understood by participants irrespective of educa-
tional attainment and was pilot tested with SA women for 
comprehension.
Two groups were conducted solely in English, and five 
in multiple languages including English, Urdu, Hindi, 
Punjabi, Pahari and Bengali. In two groups involving 
Bangladeshi women, those fluent in English assisted their 
peers so that everyone understood the language used. In 
one group which included Bangladeshi men, a woman 
acted as a translator to help a few participants take part 
in the discussion.
Analysis
Group discussions were audio recorded, translated into 
English if necessary, transcribed verbatim by a profes-
sional multilingual transcription service and checked 
against the recordings for accuracy by KEJH and NA. The 
data were analysed thematically23 using QSR Internation-
al’s NVivo V.10 Software (2012). KEJH read and reread 
the transcripts and generated initial codes. AL and NA 
also read the transcripts to identify any divergent cases, 
and initial codes were refined after discussion. Themes 
were identified deductively, guided by the discussion 
topics and inductively, as they emerged from the data. 
KEJH analysed all seven transcripts and an independent 
researcher (SG) coded two transcripts. KEJH and SG met 
to confirm any divergent cases and discuss any disagree-
ments in coding until a consensus was reached. This 
paper follows the Consolidated Criteria for Reporting 
Qualitative Studies.24
FInDIngs
A total of 49 women and 13 men took part. Demographic 
characteristics of participants are presented in table 1. 
Five themes were identified: participants’ awareness and 
knowledge of OC and genetic risk; attitudes towards 
genetic testing and finding out about OC risk; attitudes 
towards risk-stratified management; family, culture and 
religion; and accessing services.
Awareness and knowledge of OC and genetic risk
The term ovary/ovaries was not familiar to many partic-
ipants. In all groups there was some confusion over the 
ovaries, what they are and where they are located in the 
body. Some participants had difficulty distinguishing 
Table 1 Sample demographics (n=62)
n (%) 
Gender
  Female 49 (79.0)
  Male 13 (21.0)
Age
  Mean years (range) 50.5 (22–82)
Ethnic group
  Bangladeshi 31 (50.0)
  Indian 14 (22.6)
  Pakistani 15 (24.2)
  Other, Kashmiri 2 (3.2)
Approx. years lived in the UK
  Mean (range) 28.0 (2–49)
First language*
  English 8 (12.9)
  Bengali/Bangla 32 (51.6)
  Gujarati 3 (4.8)
  Hindi 5 (8.1)
  Pahari 5 (8.1)
  Punjabi 4 (6.5)
  Sylheti 1 (1.6)
  Urdu 15 (24.2)
  Missing 1 (1.6)
Religion
  Hindu 7 (11.3)
  Muslim 52 (83.9)
  Sikh 3 (4.8)
Marital status
  Married/living with partner 44 (71.0)
  Single/separated/divorced/
  widowed
17 (27.4)
  Missing 1 (1.6)
Employment
  Full-time employment 4 (6.5)
  Part-time employment 8 (12.9)
  Home maker 14 (22.6)
  Retired 14 (22.6)
  Disabled/too ill to work/full-time
  carer
3 (4.8)
  Unemployed 19 (30.6)
Education
  Degree or higher 12 (19.4)
  Qualification below degree level 19 (30.64)
  Still studying 1 (1.8)
  Other 11 (17.7)
  No formal qualifications 19 (30.6)
Continued
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between the ovaries and the womb and this was reflected 
in some Urdu speakers using the word ‘bacha daani’ 
(womb) and ‘undah daani’ (ovaries) interchangeably. 
Most participants were aware of the UK’s common cancers 
mentioning breast, prostate and lung, as well as cervical 
cancer, and correctly named some of the main risk factors 
for these. However, the majority had not come across OC 
and were unaware of the risk factors and main symptoms 
of the disease.
Ovarian cancer…no one’s heard of it. FG4, woman, 
Luton.
…I’m quite aware, I do pick up leaflets and read but I don't 
think I've come across ovarian cancer, not on TV, not on 
any sort of media, not on the train, nothing. FG3, woman, 
London.
A few women incorrectly believed that use of hormone 
replacement therapy or the contraceptive pill would 
increase a woman’s risk of OC. Older age was infre-
quently reported as a risk factor and few participants 
spontaneously spoke about family history or genetic 
risk. A minority of participants who demonstrated aware-
ness of OC explained that this was due to either having 
researched the topic online prior to the group discussion 
(n=1) or from experience of a relative with OC (n=1).
Likely due to the lack of awareness, the women had not 
considered their risk of OC. Some indicated that they did 
not generally think about their personal risk of cancer. 
When asked, most acknowledged that they would have 
some risk of OC, although whether they perceived this to 
be the same, lower or higher than others in the general 
population varied within and between the groups.
Other populations, I think it’s the same? FG1, woman, 
London.
It’s higher in Asian.
But tell me this, I have never heard of any Asian person with 
ovarian cancer. FG4, women, Luton.
Most participants had not heard of genetic testing for 
cancer risk and those that had did not know about the 
specific BRCA1/BRCA2 genes. After participants had 
been informed about genetic testing within the group, it 
became apparent that some had difficulty understanding 
that (1) the test would provide information about a 
person’s risk rather than a cancer diagnosis and (2) being 
at risk did not mean that they would definitely develop 
cancer.
Attitudes towards genetic testing and finding out about OC 
risk
Based on our presentation of genetic risk and genetic 
testing for OC, in discussion most participants initially 
expressed positive views. They felt they would benefit 
from knowing if they were at increased risk because they 
could take steps to manage their individual risk.
So you are aware of it, and you know how to prevent it, get-
ting information, what are the risks, and how to do your daily 
activity, your daily lifestyle, maybe that can change… FG2, 
woman, London.
The majority of women indicated that they would 
accept genetic testing, and several men said that they 
would encourage female family members to have testing 
if it were offered, although they acknowledged that ulti-
mately it would be the individual’s decision. Many partic-
ipants remained positive about genetic testing even after 
being told that risk information could potentially be less 
accurate for ethnic minorities. Participants said there 
were no cultural or religious prohibitions on genetic 
testing for cancer risk and these aspects of the discus-
sion prompted some Muslim participants to speak of 
the positive influence that religion has on maintaining 
good health. In one group, participants referred specif-
ically to the Imam (Muslim religious scholar), and his 
role in providing guidance to the community on health 
practices.
Your religion wants you to look after yourself. FG1, woman, 
London.
The main concerns voiced about genetic testing for OC 
risk related to experiencing worry between the blood test 
and receiving the result, and fear regarding the psycho-
logical impact of a high-risk result and what such a result 
would lead to if received.
Untilyou know the outcome, your brain will be working over-
time. FG4, woman, Luton.
Participants were not fearful of providing blood for the 
genetic test and some indicated that while they were posi-
tive about genetic testing, others might be wary since they 
may be unfamiliar with OC, genetic testing and fearful of 
cancer per se.
Negative side could be some people, maybe my mother, 
wouldn’t wanna go to that test, maybe she would be scared, 
even if she doesn’t have cancer… FG2, woman, London.
n (%) 
Attended screening
  Among female participants (breast or 
cervical screening or FOBT)
39 (79.6)
  Among male participants (FOBT) 2 (15.4)
Cancer within social network
  Yes 29 (46.8)
  No/not sure/prefer not to say 33 (53.2)
Personal cancer diagnosis
  Yes 3 (4.8)
  No/not sure/prefer not to say 59 (95.2)
*Some participants had more than one first language.
FOBT - Faecal Occult Blood Test
Table 1 Continued 
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Other negative aspects, such as the cost to the govern-
ment or concerns that the test or ‘diagnosis’ could be 
wrong or inconclusive, were infrequently discussed.
Attitudes towards risk-stratified management
Participants endorsed the risk-stratified management 
approach and accepted the information that there would 
be clear options for women at each level of risk. No 
concerns were expressed about receiving different treat-
ment based on level of risk.
…you will be able to find out what you have got and accord-
ing to that you can prevent your, you know, things as well, 
if you want to go for like a screening or for a minor surgery 
or whatever it is, it’s good to know what you have. FG1, 
woman, London.
The screening component of risk-stratified manage-
ment was generally endorsed, and participants felt that 
within their SA communities participation in current UK 
cancer screening programmes was gaining traction.
Well at least it’s something for your health, good health. 
FG3, woman, London.
It's best to take a test, best to take a test not to get to that 
stage, isn't it? FG7, man, Luton.
However, participants talked about there still being 
some within the SA community who do not accept 
cancer screening per se. A few participants, mostly men, 
suggested that some women may not see the need to 
attend screening in the absence of symptoms. Reluc-
tance to attend screening was also attributed to fear 
and issues of body privacy and shyness. Women owned 
that exposing their body to ‘someone else’ could be 
distressing, irrespective of whether the person was a 
healthcare professional.
What she’s saying is that first, Muslims were a bit scared 
and they wouldn’t get checks done. They thought that maybe 
someone else would see them… FG4, woman, Luton.
Attitudes towards risk-reducing surgery were mixed. 
While surgery was acceptable if it was deemed necessary 
by doctors, men and women said that women would not 
want surgery unless they had already had children and 
were of an older age.
It depends on age because, any lady who is 50 years up, that 
time is high risk, she needs to remove that, but 25 years, 30 
years, any lady, she has still option for children, so she can’t 
do that thing. FG2, woman, London.
Some men did not agree with risk-reducing surgery and 
believed that women would not accept it until cancer was 
diagnosed especially since ‘high risk’ did not mean the 
woman would definitely develop OC.
Until such a time that a person is diagnosed with cancer, I 
don’t think they will have their ovaries removed. FG5, man, 
Luton.
Family, culture and religion
The majority of women anticipated that their husbands 
and immediate families would support them if they had 
genetic testing for OC risk and most of the men also said 
that they would support their female family members if 
they wanted to be tested. Several women said they would 
discuss this beforehand with their husbands and families 
and/or would share the result.
And then obviously going back and discussing it with family 
what’s come up as well. FG3, woman, London.
Both men and women felt that some women would 
keep genetic testing and their result secret or ‘confiden-
tial’ from family and friends:
Some people may not want to share it with their family, want 
to keep it to themselves. FG2, woman, London.
Some women, who found the PROMISE programme 
personally acceptable, had concerns that younger women 
found to be at high risk for OC could have difficulties 
finding a husband due to the pronatalist (promotion of 
human reproduction) nature of SA culture that favours 
the healthiest women. Others expressed concern that 
identifying someone as being at high risk or deciding to 
remove the ovaries could jeopardise existing marriages.
…if you get to our age then we would say yes. But for people 
like my daughter I would advise her not to. Because maybe 
the husband would leave the wife. FG2, woman, London.
Some men indicated that they would not ask a poten-
tial partner about their cancer risk and that this would 
not influence their marital choice. Others spoke of the 
cultural importance of marriage and a woman’s ability to 
bear children where removal of the ovaries would be a 
serious issue.
A few participants expressed the view that illnesses such 
as cancer are predestined and come from God. However, 
they did not suggest that this meant they would do 
nothing to prevent illness; instead religion was referred 
to as a coping resource.
…if I find out that I have got this problem; there will going 
to be ovarian cancer. I would thank God for giving me time 
to do what I want. FG1, woman, London.
Accessing services
Participants were eager for more information to be 
provided and for OC awareness campaigns within their 
communities.
They don’t even know where it is…Where is the problem? 
How does it happen? It is very important that we give this 
information first. FG4, woman, Luton.
A variety of methods to reach SA women with key 
OC prevention, earlier diagnosis and risk management 
messages were discussed including community-based 
group sessions and campaigns in the local media targeted 
at those for whom English is not a first language. Several 
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participants suggested that as English was not their first 
language or because they could not read English, they 
would likely encounter difficulties in accessing genetic 
and screening services.
Both men and women indicated that, depending on 
the individual and situation, SA women would need or 
prefer to see a female healthcare professional, particu-
larly if a physical examination was needed.
Mostly, the issues are about female doctors checking female 
things and male doctors checking males. FG5, man, Luton.
DIsCussIOn
In this qualitative study, we identified a worrying lack of 
awareness of OC among SA women and men. Others have 
reported low awareness of cancer risk factors and symp-
toms among UK ethnic minority groups,25–28 although 
research has also shown a lack of OC symptom aware-
ness among the UK general population.28 Irrespective of 
whether risk-stratified OC management is offered to the 
public, improving awareness of OC among SAs is a health 
priority.
Some participants found it difficult to understand the 
brief presentation provided in the focus groups, it some-
times took several explanations to ensure that participants 
understood that genetic testing provides information on 
cancer risk rather than a diagnosis and that high risk did 
not mean that a person would definitely get cancer. As 
previously reported11 12 participants tended to dichoto-
mise risk as either high or low, with little discussion of 
intermediate risk. This underlines the need to develop 
optimal methods of conveying both the concept of OC 
risk and its meaning to the individual.26 27 The challenges 
of communicating risk estimates to the lay public are well 
documented and are particularly challenging29–31 when 
information materials need to be acceptable to diverse 
populations.
Our main finding that attitudes towards genetic testing 
for OC risk and stratified management were mostly posi-
tive is consistent with other studies,32 but our study identi-
fied important cultural nuances. Participants maintained 
that personal genetic testing would not be viewed nega-
tively from a religious standpoint and while a few referred 
to illness and death as predestined or from God, they 
indicated that it was still necessary to take action to main-
tain good health and, as in other research,33 religion was 
referred to as a coping strategy. Cancer fatalism was infre-
quently identified, but in this and other research,13 it was 
clear that the process of genetic testing and the receipt of 
a high-risk result was anticipated by several participants 
to create heightened anxiety. Genetic testing for OC risk 
and stratified management may not be acceptable to 
all SA women, in particular younger women. While the 
majority of women in this study indicated that they would 
accept a genetic test for OC risk if offered, many were 
already married and had children. Echoing research with 
UK Pakistanis about prenatal genetic testing34 35 and UK 
SA women with breast cancer,36 some participants were 
concerned that illness or being identified as at high risk of 
OC could damage younger women’s marriage prospects 
or cause marital problems. Participants acknowledged 
that not all SA women would discuss genetic testing or 
results with their family. Reluctance to discuss illness with 
family and friends due to taboo and perceived stigma was 
identified in the current study as well as in several other 
studies with SA participants,36 37 and could act as a barrier 
to the uptake of genetic testing.
Participants accepted the idea of stratified risk manage-
ment, that is, that there would be different management 
options for women with different levels of risk. With 
regard to the screening element of risk management, 
uptake of breast and cervical screening in the UK is lower 
among SA than white women.38 While the situation is 
slowly improving among SA women generally, change 
has not been significant for Muslim SA women.38 Inter-
estingly, in our study several groups discussed a positive 
cultural change in attitudes towards cancer screening 
and the majority reported attendance at breast and/or 
cervical screening. In line with previous research,39–41 
participants argued that lack of awareness, embarrass-
ment and shyness were barriers to attending screening. 
While OC screening with blood tests and ultrasound scans 
was seen as acceptable by most participants, the study did 
not explore the acceptability of transvaginal ultrasound 
(the most commonly used scan to help detect OC), as this 
was beyond the scope of the study. However, as reported 
elsewhere,14 33 participants did have a preference for 
consultations with a gender-matched healthcare profes-
sional, particularly if a physical examination was needed.
Risk-reducing oophorectomy was seen as a particular 
dilemma, principally due to the importance placed on 
women’s ability to bear children. Some male participants 
felt that it would be better to wait and see if a cancer 
develops, catch it at an early stage and then have surgery. 
It may be that these men were inappropriately applying 
to OC their knowledge of how other cancers present and 
develop and this needs further investigation. However, 
apprehension about this surgery is not unique to SAs.42 
Our study highlights the need for sufficient informa-
tion and support to be offered to SA women considering 
predictive genetic testing, and particularly for those with 
increased risk who will need to make risk management 
decisions.
This is the first study to explore UK SAs’ perspectives 
on population-based genetic testing and risk-stratified 
management for OC, and includes participants with 
various levels of English language who are often not 
included in research. However, the opinions expressed 
by participants with regard to genetic testing and the 
PROMISE programme were based on brief information 
which was new to all, and related issues such as insurance 
and ethics were not spontaneously discussed. Further-
more, the current study did not inform patients that an 
increased risk of OC due to a BRCA gene mutation also 
indicates an increased risk of breast cancer, as this was 
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beyond the scope of the study. The risk of breast cancer 
would further complicate decision-making as high-risk 
patients would need to consider increased surveillance 
for breast cancer or risk-reducing mastectomy. Also, both 
male focus groups were run by female facilitators; while 
participants did not express dissatisfaction with this, it 
may have influenced their responses.
Conclusions
Population-based risk assessment and stratified manage-
ment may be acceptable to many SA men and women in 
the UK. Attitudes towards cancer screening were positive; 
however, opinions on risk-reducing surgery were mixed. 
The study highlights a need for tailored OC awareness 
campaigns within SA communities. To be inclusive, 
genetic testing and aftercare services should accom-
modate non-English speakers, offer appointments with 
a gender-matched healthcare professional and offer 
patients support with their healthcare decisions.
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